Ketamine as a pharmacological tool for the preclinical study of memory deficit in schizophrenia
JES Santiago, GR Roldán, O Picazo - Behavioural Pharmacology, 2023 - journals.lww.com
Schizophrenia is a serious neuropsychiatric disorder characterized by the presence of
positive symptoms (hallucinations, delusions, and disorganization of thought and language),
negative symptoms (abulia, alogia, and affective flattening), and cognitive impairment
(attention deficit, impaired declarative memory, and deficits in social cognition).
Dopaminergic hyperactivity seems to explain the positive symptoms, but it does not
completely clarify the appearance of negative and cognitive clinical manifestations …
positive symptoms (hallucinations, delusions, and disorganization of thought and language),
negative symptoms (abulia, alogia, and affective flattening), and cognitive impairment
(attention deficit, impaired declarative memory, and deficits in social cognition).
Dopaminergic hyperactivity seems to explain the positive symptoms, but it does not
completely clarify the appearance of negative and cognitive clinical manifestations …
以上显示的是最相近的搜索结果。 查看全部搜索结果